The role of 5α‐reductase inhibitors in gastro‐oesophageal cancer risk : A nested case‐control study

Busby , J , Karasneh , R , Murchie , P , McMenamin , Ú , Gadalla , S M , Camargo , M C , Iversen , L , Lee , A J , Spence , A D & Cardwell , C R 2020 , ' The role of 5α‐reductase inhibitors in gastro‐oesophageal cancer risk : A nested case‐control study ' , Pharmacoepidemiology and Drug Safety , vol. 29 , no. 1 , pp. 48-56 . https://doi.org/10.1002/pds.4909

URI

https://hdl.handle.net/2164/15355

DOI

https://doi.org/10.1002/pds.4909

Rights

This is the peer reviewed version of the following article: Busby, J, Karasneh, R, Murchie, P, et al. The role of 5α‐reductase inhibitors in gastro‐oesophageal cancer risk: A nested case‐control study. Pharmacoepidemiol Drug Saf. 2020; 29: 48– 56., which has been published in final form at https://doi.org/10.1002/pds.4909. This article may be used for non-commercial purposes in accordance with Wiley Terms and Conditions for Use of Self-Archived Versions.

Collections

All research


	The Sir Duncan Rice Library University of Aberdeen Bedford Road Aberdeen AB24 3AA Tel: +44 (0)1224 273330 Email: library@abdn.ac.uk